MGC Pharmaceuticals Ltd (MXC) Company Profile

MGC Pharmaceuticals Ltd Company Snapshot

MGC Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares MGC Pharmaceuticals Ltd with three other companies in this sector in Australia: Prescient Therapeutics Ltd (2017 sales of 166,220.00 Australian Dollars [US$129,354.07 ] ), Creso Pharma Ltd (342,251.00 Australian Dollars [US$266,343.15 ] ), and Bod Australia Ltd (352,877.00 Australian Dollars [US$274,612.41 ] ).

Sales Analysis.

MGC Pharmaceuticals Ltd

Stock Data:

Recent Stock Performance:

Current Price (4/20/2018): .08
(Figures in Australian Dollars)

1 Week	-12.2%	13 Weeks	-9.2%

4 Weeks	-21.0%	52 Weeks	31.7%

MGC Pharmaceuticals Ltd Key Data:

Ticker:	MXC	Country:	Australia

Exchanges:		Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2017 Sales	247,500 (Year Ending Jan 2018).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	86,632,088

Fiscal Yr Ends:	June	Shares Outstanding:	1,096,608,703

Share Type:	Ordinary	Closely Held Shares:	220,746,197

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.